Drug Shortage Report for APO-SITAGLIPTIN/METFORMIN XR
Report ID | 185985 |
Drug Identification Number | 02506297 |
Brand name | APO-SITAGLIPTIN/METFORMIN XR |
Common or Proper name | SITAGLIPTAN PHOSPHATE/METFORMIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
Strength(s) | 1000MG 100MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-03-02 |
Estimated end date | 2024-01-31 |
Actual end date | 2024-02-01 |
Shortage status | Resolved |
Updated date | 2024-02-02 |
Company comments | Product on allocation due to increased demand |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v29 | 2024-02-02 | French | Compare |
v28 | 2024-02-02 | English | Compare |
v27 | 2024-01-05 | French | Compare |
v26 | 2024-01-05 | English | Compare |
v25 | 2023-12-22 | French | Compare |
v24 | 2023-12-22 | English | Compare |
v23 | 2023-12-01 | French | Compare |
v22 | 2023-12-01 | English | Compare |
v21 | 2023-11-06 | French | Compare |
v20 | 2023-11-06 | English | Compare |
v19 | 2023-09-28 | French | Compare |
v18 | 2023-09-28 | English | Compare |
v17 | 2023-09-01 | French | Compare |
v16 | 2023-09-01 | English | Compare |
v15 | 2023-07-27 | French | Compare |
v14 | 2023-07-27 | English | Compare |
v13 | 2023-06-29 | French | Compare |
v12 | 2023-06-29 | English | Compare |
v11 | 2023-05-12 | French | Compare |
v10 | 2023-05-12 | English | Compare |